跳至主要内容
临床试验/NCT03949192
NCT03949192Unknown不适用

Efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma: A Prospective Exploratory Clinical Study

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年6月28日最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
Changes in tumor volume

研究概览

简要总结

A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient signed "informed consent" voluntarily;
  • The age of patient is between 18 and 80 years;
  • KPS score ≥40 ; The patient has normal liver and kidney function Normal heart function Better follow-up and compliance;

排除标准

  • The patient did not sign "informed consent" or signed unvoluntarily.
  • Non-glioma patients
  • Active infection
  • Human immunodeficiency virus (HIV) positive
  • Hepatitis C or hepatitis B infective
  • Pregnancy or breast-feeding women
  • Patients did not agree to use effective contraception during treatment and the following 3 months.
  • Patients also participated in other clinical studies.
  • The subjects researchers believe are not suitable for participation or completion of the study.

结局指标

主要结局

Changes in tumor volume

时间窗: 3 months

the volume of tumor decreased after taking Kangliuwan

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qingtang Lin

assistant director physician

Xuanwu Hospital, Beijing

研究点 (1)

Loading locations...

相似试验